1. Academic Validation
  2. A Bivalent Activatable Fluorescent Probe for Screening and Intravital Imaging of Chemotherapy-Induced Cancer Cell Death

A Bivalent Activatable Fluorescent Probe for Screening and Intravital Imaging of Chemotherapy-Induced Cancer Cell Death

  • Angew Chem Weinheim Bergstr Ger. 2022 Jan 26;134(5):e202113020. doi: 10.1002/ange.202113020.
Nicole D Barth 1 Lorena Mendive-Tapia 1 Ramon Subiros-Funosas 1 Ouldouz Ghashghaei 2 Rodolfo Lavilla 2 Laura Maiorino 3 Xue-Yan He 3 Ian Dransfield 1 Mikala Egeblad 3 Marc Vendrell 1
Affiliations

Affiliations

  • 1 Centre for Inflammation Research The University of Edinburgh UK.
  • 2 Laboratory of Medicinal Chemistry Faculty of Pharmacy and Institute of Biomedicine (IBUB) University of Barcelona Spain.
  • 3 Cold Spring Harbor Laboratory Cold Spring Harbor NY 11724 USA.
Abstract

The detection and quantification of apoptotic cells is a key process in Cancer research, particularly during the screening of Anticancer therapeutics and in mechanistic studies using preclinical models. Intravital optical imaging enables high-resolution visualisation of cellular events in live organisms; however, there are few fluorescent probes that can reliably provide functional readouts in situ without interference from tissue autofluorescence. We report the design and optimisation of the fluorogenic probe Apotracker Red for real-time detection of Cancer cell death. The strong fluorogenic behaviour, high selectivity, and excellent stability of Apotracker Red make it a reliable optical reporter for the characterisation of the effects of Anticancer drugs in cells in vitro and for direct imaging of chemotherapy-induced Apoptosis in vivo in mouse models of breast Cancer.

Keywords

apoptosis; breast cancer; chemotherapy; fluorogenic probes; peptides.

Figures
Products